Experimental Immunotherapy Could Help High-Risk Bladder Cancer Patients Skip Cystectomy
A Mayo Clinic–led international phase 3 trial reports that a new intravesical oncolytic immunotherapy, cretostimogene grenadenorepvec, may help many people ...
Tag: bladder cancer immunotherapy
Type I Interferon β Boosts Anti-Tumor Activity in Bladder Cancer
In recent advancements in the field of cancer immunotherapy, researchers have made a significant breakthrough in harnessing the power of ...
Boosting PPARγ Upregulates NECTIN4, Enhances CAR-T
In the relentless fight against bladder cancer, a groundbreaking study published in Nature Communications unveils a transformative strategy that could ...
Decades-Old Bladder Cancer Treatment Yields New Insights to Enhance Immunotherapy Advances
A venerable cornerstone of cancer immunotherapy, the Bacillus Calmette-Guérin (BCG) vaccine, long used to combat tuberculosis and as a first-line ...
Breakthrough Discoveries in Bladder Cancer Treatment Pave the Way for Enhanced Immunotherapies
More than thirty years ago, the U.S. Food and Drug Administration (FDA) made a landmark decision by approving Bacillus Calmette-Guérin ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!